|
RxNorm
|
Resource Development
|
FDA
|
NLM
|
RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software. By providing links between these vocabularies, RxNorm can mediate messages between systems not using the same software and vocabulary.
|
|
Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NHLBI, NIAID, NIDCR, NIDDK
|
Experienced investigators come to the National Institutes of Health (NIH) to learn about management of a clinical research enterprise, including topics such as planning and budget development, protocol writing and tracking, and scientific review. Sabbaticals are self-directed, meaning that the participant chooses from a list of electives and helps determine how much time to spend studying each topic. The electives are offered by leaders at the NIH and other US Department of Health and Human Services agencies with the NIH Clinical Center being the most heavily involved.
|
|
Safe to Sleep
|
Public Education Campaign
|
CDC, HRSA
|
NICHD
|
The Safe to Sleep; campaign seeks to educate parents and caregivers about ways to reduce the risk of Sudden Infant Death Syndrome (SIDS) and other sleep-related causes of infant death, such as accidental suffocation. The National Institute of Child Health and Human Development (NICHD) offers print and electronic materials, media resources, toolkits, and a continuing education program for nurses to help spread the word about safe infant sleep. The Safe to Sleep; campaign partners with organizations to help reach various audiences, including African American, and American Indian/Alaska Native communities, which have the highest SIDS rates of any racial/ethnic group in the United States.
|
|
SAMHSA Recovery Month
|
Public Education Campaign
|
SAMHSA
|
NIDA
|
The Substance Abuse and Mental Health Services Administration (SAMHSA) holds an annual public health observance for people in recovery from substance abuse. The National Institute on Drug Abuse (NIDA) is part of SAMHSA's inter-agency planning committee and a promotional partner.
|
|
SARS-CoV-2 Assay Development, Training, and Standardization
|
Resource Development
|
FDA
|
NIAID
|
SARS-CoV-2 Assay Development, Training, and Standardization in BSL4 lab at Integrated Research Facility, Fort Dietrick
|
|
SARS-CoV-2 Assessment of Viral Evolution Program (SAVE)
|
Committee, Work group, Advisory group, or Task Force
|
FDA, CDC, ASPR
|
NIAID
|
SAVE provides a comprehensive real-time risk assessment of emerging mutations in SARS-CoV-2 that could impact transmissibility, virulence, and susceptibility to infection- or vaccine-induced immunity. The goals of the SAVE program are to understand emerging changes in the virus that could impact transmissibility, virulence, susceptibility to convalescent and vaccine-induced immunity and diagnostic testing.
|
|
SARS-CoV-2 evolution in immunocompromised people
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NIAID
|
Working Group that performs a systematic literature review in the area of immunocompromised patients with prolonged SARS-CoV-2 infections. The aim is to assess potential risk factors that may lead to intra-host evolution of the virus.
|
|
SARS-CoV-2 Interagency Group on Resistance to Medical Countermeasures (MCMs)
|
Committee, Work group, Advisory group, or Task Force
|
ASPR, CDC, FDA
|
NIAID
|
SARS-CoV-2 interagency Working Group with vaccine, therapeutics, and diagnostics subgroups
|
|
SARS-CoV-2 Pathogenesis
|
Research Initiative
|
FDA
|
OD/OIR, NIAID
|
SARS-CoV-2 Pathogenesis
|
|
SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)
|
Other
|
CDC
|
NLM, NIAID
|
To help accelerate the use of near-realtime pathogen genomic data throughout the pandemic response, CDC established an open genomics consortium to spearhead and organize public health sequencing and response efforts across the United States. This consortium, SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES), helps coordinate and support sequencing at state and local public health laboratories across the country, and to better engage clinical, academic and commercial laboratories that are sequencing, or planning to sequence -- SARS-CoV-2 at any scale. The coalition aims to improve communication and knowledge-sharing between US laboratories, to develop consensus guidance on data and metadata standards, to reduce barriers to bioinformatic analysis and data sharing, and to better align sequencing requirements and resource needs with different sources of funding, technology, expertise and Other means of support.
|